CDC - Grand Rounds ► Lyme Disease: Challenges and Innovations ► Tuesday, June 18, at 1 p.m. - 2 p.m., EDT

CDC - Grand Rounds

Join us next week for an encore presentation of CDC’s Public Health Grand Rounds, “Lyme Disease: Challenges and Innovations.” This session will be available via webcast from CDC headquarters in Atlanta, Georgia on Tuesday, June 18 at 1 p.m. (EDT) at www.cdc.gov/about/grand-rounds. The webcast link is only active during the date and time of the session, but all sessions are archived for future viewing.

Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.

On May 19, 2011, Dr. Allen Steere joined an esteemed panel of Grand Rounds speakers to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gave a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.

Presented by:

Paul Mead, MD, MPH
Chief, Epidemiology and Surveillance Activity, Bacterial Disease Branch,
Division of Vector-borne Infectious Diseases, NCEZID, CDC
“Ecology, Epidemiology and Prevention of Lyme Disease in the United States”

Allen Steere, MD
Director of Clinical Research, Rheumatology Unit, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
“Clinical and Treatment Challenges”

Adriana Marques, MD
Chief, Clinical Studies Unit, Laboratory of Clinical Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
“Diagnostic Testing for Lyme Disease”

Ruth Lynfield, MD
State Epidemiologist
Minnesota Department of Health
“A State Perspective”

Facilitated by:

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds
John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds

Grand Rounds is available for Continuing Education. Learn more about continuing education on the Grand Rounds website.   

Next Grand Rounds Presentation (Encore):

Lyme Disease: Challenges and Innovations

Tuesday, June 18, at 1 p.m. - 2 p.m., EDT
Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy. Please join us for this encore presentation for a rare glimpse into the front lines of those battling and treating Lyme disease.
Read More
Future Grand Rounds topics include cancer screening.
Watch the live webcast with a broadband or slower connection.
Flash option for Apple Users: http://www.onlinevideo
service.com/clients/CDC/?mount=CDC3
If you are unable to connect using the link, copy and paste the link into your web browser. Captions are only available on the Windows Media links. The webcast links are only active during the date and time of the session, but all sessions are archived for future viewing